 mir-27b expression is associated with survival in triple negative breast cancer patients.Inhibition of miR-27 by antisense molecules decreases cell proliferation.Antisense RNA directed against miR-27a has been shown to decrease the percentage of cells in S phase whilst also increasing those in the G2-M phase.